MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer

被引:17
作者
Gu, Lina [1 ]
Sang, Meixiang [1 ,2 ]
Yin, Danjing [1 ]
Liu, Fei [1 ]
Wu, Yunyan [1 ]
Liu, Shina [1 ]
Huang, Weina [1 ]
Shan, Baoen [1 ,2 ]
机构
[1] Hebei Med Univ, Res Ctr, Hosp 4, 14 Jiankang Rd, Shijiazhuang 050017, Hebei, Peoples R China
[2] Hebei Med Univ, Tumor Res Inst, Hosp 4, Shijiazhuang, Hebei, Peoples R China
关键词
Biological marker; lung cancer; MAGE; metastasis; prognosis; CIRCULATING TUMOR-CELLS; CLINICAL-SIGNIFICANCE; BREAST-CANCER; STATISTICS; ANTIGEN;
D O I
10.1111/1759-7714.12571
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundMAGE-A genes belong to the cancer/testis antigens family. The prognostic significance of MAGE-A expression in the peripheral blood of patients with lung cancer is unknown. Therefore, this study evaluated the expression and possible prognostic significance of MAGE-A in the peripheral blood of patients with lung cancer. MethodsIn this study, we detected MAGE-A gene expression in the peripheral blood of 150 patients with lung cancer and 30 healthy donors using multiplex semi-nested PCR and analyzed their correlation with clinicopathological risk factors. ResultsMAGE-A expression was associated with factors indicating poor prognosis. The expression of MAGE-A and each individual MAGE-A gene were also associated with low overall survival in patients with lung cancer. ConclusionThe expression of MAGE-A genes in peripheral blood may act as a poor prognostic marker in patients with lung cancer.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 22 条
[21]   Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and IMAGE-A12 gene promoters [J].
Wischnewski, Frank ;
Friese, Olaf ;
Pantel, Klaus ;
Schwarzenbach, Heidi .
MOLECULAR CANCER RESEARCH, 2007, 5 (07) :749-759
[22]  
Zhang SY, 2015, INT J CLIN EXP PATHO, V8, P541